Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Solutions × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 6 Neoplasms 5 Melanoma 3 Neoplasm Metastasis 2 Hematologic Neoplasms 2 Hemangioma 2 Warts 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors Harboring NTRK Fusion 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Seizures 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Pelvic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Nonmelanoma Skin Cancers 1 Mucositis 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lymphoma, T-Cell 1 Lung Neoplasms 1

Interventions

Carboplatin 293 Cisplatin 214 Radiotherapy 186 Paclitaxel 174 Pemetrexed 161 Docetaxel 150 Gemcitabine 138 pembrolizumab 127 Erlotinib Hydrochloride 96 Magnetic Resonance Spectroscopy 90 Etoposide 88 Bevacizumab 77 Specimen Handling 73 durvalumab 66 Radiosurgery 64 Nivolumab 64 Vinorelbine 50 Drug Therapy 50 Blood Specimen Collection 50 osimertinib 47 Gefitinib 42 Surveys and Questionnaires 38 Biopsy 38 atezolizumab 37 Irinotecan 36 Topotecan 35 Radiation 35 Cyclophosphamide 35 Standard of Care 33 Surgical Procedures, Operative 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00210080 2015-09-04

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

Merck Sharp & Dohme LLC

Phase 3 Completed

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡